Trump talks big on pharma tariffs, and then there is reality

ANALYSIS: The global pharmaceutical industry has been bracing for US tariffs all year. Now they have been announced, the impact may not be as dramatic as feared.

WATCH: NBR senior journalist Lachlan Colquhoun speaks with Simon Shepherd.

“Thank you for your attention to this matter!”

The Truth Social post from US President Donald Trump ended with his regular signoff, and he announced the imposition of 100% tariffs on pharmaceutical imports to the US last week.

Driving his agenda of reinvigorating American manufacturing, he also

Want to read more? It's easy.

Choose your subscription

Already have an account? Login

Smartphone Only Subscription

NZ$29.95 / monthly

Monthly Premium Online Subscription

NZ$49.95 / monthly

Smartphone Only Annual Subscription

NZ$299.00 / yearly

Yearly Premium Online Subscription

NZ$499.00 / yearly

Premium Group Membership 10 Users

NZ$385+GST / monthly

$38.5 per user - Pay by monthly credit card debit

Premium Group Membership 20 Users

NZ$660+GST / monthly

$33 per user - Pay by monthly credit card debit

Premium Group Membership 50 Users

NZ$1375+GST / monthly

$27.5 per user - Pay by monthly credit card debit

Premium Group Membership 100 Users

NZ$2100+GST / monthly

$21 per user - Pay by monthly credit card debit

Yearly Premium Online Subscription + NBR Marketplace

NZ$999.00 / yearly

Individual

Group membership

NBR Marketplace

Student

Exclusive FREE offer for uni students studying at a New Zealand university (valued at $499).

View terms and conditions.

Lachlan Colquhoun Wed, 01 Oct 2025

Contact the Writer: lachlan@nbr.co.nz

News tip? Question? Typo? Let us know: editor@nbr.co.nz

Categories

Analysis

Featured